10.1021/ja01691a008 584 SvedbergT.PedersenK
Compounded products are associated with significant risks and are not FDA approved
Proteotoxicity and cardiac dysfunction
This paper reviews the Met metabolism in normal conditions and its dysregulation under abnormal conditions, the possible causes of hypermethioninemia, and its connection to BA pathogenesis: Abnormal hepatic level of Met could lead to a perturbation of redox homeostasis and mitochondrial functions of hepatocytes, enhancement of viral infectivity, and dysregulation of innate and adaptative immune cells in response to infection/damage of the liver contributing to the initiation/progression of BA
Sold as Vyleesi, bremelanotide was approved in 2019 for premenopausal women with acquired, generalised HSDD clinically defined as low sexual desire causing significant personal distress
Wrong reconstitution volume Mistake : Adding 5ml water thinking "5mg = 5ml." Problem : Makes concentration too weak, unnecessarily large injections